The cocktail of antibodies that President Donald Trump is taking as part of his treatment regimen is aimed at helping boost the human immune system to beat COVID-19, the co-founder of the company that makes it said on Saturday.
“It’s all about beating the virus and so we’re just helping the natural immune system beat it, by supplementing it with this antibody cocktail,” Dr. George Yancopoulos, the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals, said during an appearance on Fox News’ “Cavuto Live.”